FDA Panel , Endorses br COVID Vaccines, for Children Under 5.br On June 15, an advisory panel to the United States br Food and Drug Administration voted to recommend br two COVID-19 vaccines for kids ages 5 and under.br Yahoo reports that both PfizerBioNTech br and Moderna were under review by the panel. .br The unanimous FDA panel vote br is the first step in what is predicted br to be a quick authorization process.br According to Yahoo, data from trials shows br that both vaccines continue to protect against severe disease, hospitalization and death.br According to Yahoo, data from trials shows br that both vaccines continue to protect against severe disease, hospitalization and death.br Yahoo reports that parents now br have two options for how br to vaccinate their children.br Pfizer's vaccine for kids is delivered in three, br three-microgram doses, while Moderna's vaccine br is delivered in two shots of a 25-microgram dose.br Our robust clinical study shows that br three doses can provide protection for br the circulating Omicron variant and br offers promise for protection against br potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research br and Development head, via Yahoo.br Our robust clinical study shows that br three doses can provide protection for br the circulating Omicron variant and br offers promise for protection against br potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research br and Development head, via Yahoo.br The committee’s support today br is imperative to providing a critical tool br for pediatricians, parents, and caregivers br who eagerly await an option br for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo.br Both companies are now awaiting approval from br the FDA and the CDC which will hold an advisory br committee meeting on the topic over the weekend.